Adipokines: Endocrine relationship between obesity and type II diabetes

  • Autran José Silva Jr Centro Universitário da Fundação Educacional de Guaxupé / UNIFEG
Keywords: Adipokines, Obesity, Type 2 diabetes mellitus

Abstract

Study Model: literature review. Introduction: Adipose tissue produces many peptides and non-peptides called adipokines that act on metabolic control and activity. Aim: The study aims an explanatory model that links obesity with type 2 diabetes from these adipokines. Methodology: The literature review consisted of consultation in databases: Scientific Electronic Library Online (Scielo) Highwire, PubMed in January 2000 period to date. Two analyzes were performed, the first used the descriptors obesity and adipokines and type 2 diabetes and adipokines, for a total of 6 combinations. The need for a second analysis was because the first were observed an excessively large number, and so needed a new refinement. The descriptors and their combinations in Portuguese, English and Spanish literature used for selection in the second analysis in the electronic media were: obesity and type 2 diabetes and tumor necrosis factor; obesity and type 2 diabetes and interleukin 6; obesity and type 2 diabetes and resistin; obesity and type 2 diabetes and adiponectin. Results: We selected 40 articles, which were related to obesity, diabetes and adipokines. Conclusion: The proposed model appears to be consistent, because numerous studies individually relate the effects of adipokines. Knowing these effects, releasing and inhibiting factors and the proposed model, it is essential for a good understanding of the association between the two conditions studied and thus propose new methods of control.

References

-Ahima, R. S.; Flier, J. S. Adipose tissue as an endocrine organ. TEM. Vol. 11. Núm. 8.p. 327-332. 2000.

-Ahima, R. S. Adipose tissue as an endocrine organ. Obesity. Vol. 14. p. 242S-249S. 2006.

-Almanza-Pérez, J. C.; Blancas-Flores, G.; Garcia-Maacedo, R.; Alarcón-Aguilar, F. J.; Cruz, M. Leptina y su relación con la obesidad y la diabetes mellitus tipo 2. Gac Méd Méx. Vol. 144. Núm. 6. p. 535-542. 2008.

-Al-Salam, S.; Rashed, H.; Adeghate, E. Diabetes mellitus is associated with an increased expression of resistin in human pancreatic islet cells. Islets. Vol. 3. Núm. 5. p. 246-249. 2011.

-Bastard, J. P.; Maachi, M.; Lagathu, C.; Kim, M. J.; Caron, M.; Vidal, H. et al Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. Vol. 17. Núm. 1. p. 4-12. 2006.

-Blachnio-Zabielskaa, A. U.; Koutsaria, C.; Tchkoniab, T.; Jensena, M. D. Sphingolipid content of human adipose tissue: relationship toadiponectin and insulin resistance. Obesity. Vol. 20. Núm. 12. p. 2341-2347. 2012.

-Blüher, M.; Bullen, J. W.; Lee, J. H.; Kralisch, S.; Fasshauer, M.; Klöting, N.; e colaboradores. Circulating Adiponectin and Expression of Adiponectin Receptors in Human Skeletal Muscle: Associations with Metabolic Parameters and Insulin Resistance and Regulation by Physical Training. J Clin Endocrinol Metab. Vol. 91. Núm. 6. p. 2310-2316. 2006.

-Carvalheira, J. B. C.; Zecchin, H. G.; Saad, M. J. A. Vias de Sinalização da Insulina. Arq Bras Endocrinol Metab. Vol. 46. Núm. 4. p. 419-425. 2002.

-Costa, J. V.; Duarte, J. S. Tecido adiposo e adipocinas. Acta Med Port. Vol. 19. p. 251-256. 2006.

-Curat, C. A.; Miranville, A.; Sengene’s, C.; Diehl, M.; Tonus, C.; Busse,R.; e colaboradores. From blood monocytes to adipose tissue–resident macrophages induction of diapedesis by human mature adipocytes. Diabetes. Vol. 53. p. 1285-1292. 2004.

-Dunmore, S. J.; Brown, J. E. P. The role of adipokines in b-cell failure of type 2 diabetes. Journal of Endocrinology. Vol. 216. Núm. 1. p. t37-t45. 2013.

-Fantuzzi, G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. Vol. 115. Núm. 5. p. 911-919. 2005.

-Finucane, M. M.; Stevens, G. A.; Cowan, M.; Danaei, G.; Lin, J. K. National, regional, and global trends in body mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. Vol. 377. Núm. 9765. p. 557-567. 2011.

-Fonseca-Alaniz, M. F.; Takada, J.; Alonso-Vale, M. I. C.; Lima, F. B. O tecido adiposo como centro regulador do metabolismo.Arq Bras Endocrinol Metab. Vol. 50. Núm. 2. p. 216-229. 2006.

-Francischi, R. P. P.; Pereira, L. O.; Freitas, C. S.; Klopfer, M.; Santos, R. C.; Vieira, P.; Lancha Jr, A. H. Obesidade: atualização sobre sua etiologia, morbidade e tratamento. Rec. Nutr. Vol. 13. Núm. 1. p. 17-28. 2000.

-Instituto Brasileiro de Geografia e Estatística (IBGE). Pesquisa de Orçamentos Familiares (POF) 2008 -2009. Antropometria e estado nutricional de crianças, adolescentes e adultos no Brasil. Rio de Janeiro. IBGE. 2010.

-Kadowaki, T.; Yamauchi, T.; Kubota, N.; Hara, K.; Ueki, K.; Tobe, K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. The Journalof Clinical Investigation. Vol. 116. Núm. 7. p. 1784-1792. 2006.

-Kershaw, E. E.; Flier, J. S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. Vol. 89. Núm. 6. p. 2548-2556. 2004.

-Kusminski, C. M.; McTernan, P. G.; Kumar, S. Role of resistin in obesity, insulin resistance and Type II diabetes. Clinical Science. Vol. 109. p. 243-256. 2005.

-Leite, L. D.; Rocha, E. D. M.; Brandão-Neto, J. Obesidade: uma doença inflamatória. Revista Ciência & Saúde. Vol. 2. Núm. 2. p. 85-95. 2009.

-Luchs, A. Transdução de sinal: um olhar sobre a insulina. Rev Inst Adolfo Lutz. Vol. 65. Núm. 3. p. 157-164. 2006.

-Mclellan, K. C. P.; Barbalho, S. M., Cattalini, M.; Lerario, A. C. Diabetes mellitus do tipo 2, síndrome metabólica e modificação no estilo de vida. Rev. Nutr. Vol. 20. Núm. 5. p. 515-524. 2007.

-Motawi, T.; Salman, T.; Shaker, O.; Abdelhamid, A. Associationof polymorphism in adiponectin (+45 T/G) and leptin (-2548 G/A) genes with type 2 diabetes mellitus in male Egyptians. Arch Med Sci. Vol. 5. p. 937-944. 2015.

-Nelson, D. L.; Cox, M. M. Lehninger princípios de bioquímica. 4ª edição. São Paulo. Editora Sarvier. p. 626-631. 2006.

-Organização Pan-Americana da Saúde. Doenças crônico-degenerativas e obesidade: estratégia mundial sobre alimentação saudável, atividade física e saúde. Brasília. 2003.

-Ozes, O. N.; Akca, H.; Mayo, L. D.; Gustin, J. A.; Maehama, T.; Dixon, J. E. et al phosphatidylinositol 3-kinaseyAktymTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proceedings of the National Academy of Sciense of the United State of America. Vol. 98. Núm. 8. p. 4640-4645. 2001.

-Park, H. K.; Ahima, R. S. Resistin in Rodents and Humans. Diabetes Metab J. Vol. 37. p. 404-414. 2013.

-Pereira, L. O.; Francischi, R. P.; Lancha Jr, A. H. Obesidade: hábitos nutricionais, sedentarismo e resistência à insulina. Arq Bras Endocrinol Metab. Vol. 47. Núm. 2. p. 111-127. 2003.

-Pinto, W. J. A função endócrina do tecido adiposo. Rev. Fac. Ciênc. Méd. Sorocaba. Vol. 16. Núm. 3. p. 111-120. 2014.

-Reyes, J. A. O.; Plancarte, A. Bases moleculares de las acciones de la insulina. Revista de Educación Bioquímica. Vol. 27. Núm. 1. p. 9-18. 2008.

-Rotter, V.; Nagaev, I.; Smith, U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. The Journal of Biological Chemistry. Vol. 278. Núm. 46.p. 45777-45784. 2003.

-Senn, J. J.; Klover, P. J.; Nowak, I. A.; Zimmers, T. A.; Koniaris, L, G.; Furlanetto, R. W. et al. Suppressor of Cytokine Signaling-3 (SOCS-3), a Potential Mediator of Interleukin-6-dependent Insulin Resistance in Hepatocytes. The Journal of Biological Chemistry. Vol. 278. Núm. 16. p. 13740-13746. 2003.

-Speretta, G. F. F.; Leite, R. D.; Duarte, A. C. O. Obesidade, inflamação e exercício: foco sobre o TNF-alfa e IL-10. Revista HUPE. Vol. 13. Núm. 1. p. 61-69. 2014.

-Srikanthan, K.; Feyh, A.; Visweshwar, H.; Shapiro, J. I.; Sodhi, K. Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the West Virginian population. International Journal of Medical Sciences. Vol. 13. Núm. 1. p. 25-38. 2016.

-Steppan, C. M.; Bailey, S. T.; Bhat, S.; Brown, E. J.; Banerjee, R. R.; Wright, C. M.The hormone resistin links obesity to diabetes. Nature. Vol. 409. p. 307-312. 2001.

-Thong, F. S. L.; Dugani, C. B.; Klip, A. Turning signals on and off: GLUT4 traffic in the insulin-signaling highway. Physiology. Vol. 20. Núm. 5. p. 271-284. 2005.

-Weisberg, S. P.; McCann, D.; Desai, M.; Rosenbaum, M.; Leibel, R. L.; Ferrante Junior, A. W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. Vol. 112. p. 1796-1808. 2003.

-Wellen, K.E.; Hotamisligil, G. S. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. Vol. 112. Núm. 12. p. 1785-1788. 2003.

-Whitehead, J. P.; Richards, A. A.; Hickman, I. J.; Macdonald, G.A.; Prins, J. B. Adiponectin -a key adipokine in the metabolic syndrome. Diabetes, Obesity and Metabolism Vol. 8. p. 264-280. 2006.

-Yamauchi, T.; Kadowaki, T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. International Journal of Obesity Vol. 32. p. s13-s18. 2008.

Published
2017-02-28
How to Cite
Silva Jr, A. J. (2017). Adipokines: Endocrine relationship between obesity and type II diabetes. Brazilian Journal of Obesity, Nutrition and Weight Loss, 11(63), 135-144. Retrieved from https://www.rbone.com.br/index.php/rbone/article/view/504
Section
Scientific Articles - Original